Skip to content
“The trial is designed to assess the safety and performance of a new approach to aortic valve replacement,” says G. Michael Deeb, M.D. , the Herbert Sloan Collegiate Professor of Surgery and principal investigator for the trial at U-M.
The presence of bacteria in an unexpected place suggests that a vicious cycle of inflammation and microbiome disruption may influence illnesses such as sepsis and acute lung failure.
Back to Archive